Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of cimetidine as an adjunct to standard therapy for acute extrinsic atopic dermatitis with elevated IgE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimetidine (CIMETIDINE)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Atopic Dermatitis, Immunoglobulin E Concentration, Serum | Phase 3 | Status: UNKNOWN